Preeclampsia could be treated with 'blood filtering' therapy, early study hints
A pilot study suggests that a blood-filtering therapy for preeclampsia is safe for both pregnant individuals and their fetuses. The treatment aims to reduce levels of a placental protein linked to the condition, which currently has no effective post-diagnosis intervention. Larger trials are needed to assess the therapy's effectiveness.
- ▪Preeclampsia affects up to 8% of pregnancies and can be life-threatening for both mother and baby.
- ▪The only current treatment for preeclampsia is delivery, which can lead to premature birth and associated health risks.
- ▪The new blood-filtering therapy targets a placental protein believed to play a role in the development of preeclampsia.
Live Science files mainly under science. We currently carry 137 of its stories.
Story provenance
Source · retrieval · rights · ranking — open for full record
inspect →
Story provenance
Attribution is not the same as permission. This drawer separates discovery metadata, excerpts, WeSearch-generated summaries, reuse status, and whether the publisher receives the visit. Nothing here claims a legal grant the publisher has not made.
Record
| Original publisher | Live Science |
| Canonical URL | https://www.livescience.com/health/reproductive-health/preeclampsia-could-be-treated-with-blood-filtering-therapy-early-study-hints |
| Publication time | Tue, 28 Apr 2026 18:54:38 +0000 |
| Retrieval time | 2026-04-28T19:02:29.558Z |
| Last seen | 2026-04-28T19:02:29.558Z |
| Headline source | Publisher (no WeSearch rewrite) |
| Excerpt source | publisher body |
| Excerpt method | First ~120 words (~800 chars) of extracted publisher body, fair-use limited. |
| Summary | WeSearch · cerebras-chat (WeSearch summarizer) |
| Summary source text | contentText |
| Citation coverage | Summary is a WeSearch-generated derivative; primary citation is the original publisher URL. |
| Cluster | 5iquMBYQWZk5 |
| Cluster logic | Grouped by semantic title/content similarity across sources within a rolling window. Same-publisher template collisions are excluded from coverage comparison. |
| Ranking reason | Story pages are not engagement-ranked. Hub feeds use recency, with optional source-diversified chronological ordering (cap consecutive stories per source). No personalized ranking. |
| Publisher visit | Yes — open original |
| Substitutes article? | No — link-out required for full text |
Rights status (four layers)
WeSearch handling by dimension
| Indexing | May the item be indexed (stored, ranked, made findable)? | Allowed |
| Snippet | May a short excerpt of the publisher's text be shown? | Allowed |
| AI summary | May WeSearch generate its own short summary of the article? | Limited |
| Retrieval / RAG | May the content be exposed for third-party retrieval-augmented generation? | Not asserted |
| Model training | May the content be used to train AI models? | Not asserted |
| Commercial reuse | May the content be reused commercially? | Not permitted |
Basis: Derived from the published RSS/Atom feed. Contact: [email protected]. Reviewed: 2026-07-24.
Opening excerpt (first ~120 words) tap to expand
Health Reproductive Health Preeclampsia could be treated with 'blood filtering' therapy, early study hints A blood-filtering therapy for preeclampsia is safe for pregnant patients and their babies, according to a new pilot study. By Lauren Schneider published 28 April 2026 in News When you purchase through links on our site, we may earn an affiliate commission. Here’s how it works. Preeclampsia, a hypertensive condition that affects up to 8% of pregnancies, can be life-threatening for mothers and babies.
…
Excerpt limited to ~120 words for fair-use compliance. The full article is at Live Science.
Discussion
0 commentsMore from Live Science
